-
1por M. Kelley Erb, Daniel R. Karlin, Bryan K. Ho, Kevin C. Thomas, Federico Parisi, Gloria P. Vergara-Diaz, Jean-Francois Daneault, Paul W. Wacnik, Hao Zhang, Tairmae Kangarloo, Charmaine Demanuele, Chris R. Brooks, Craig N. Detheridge, Nina Shaafi Kabiri, Jaspreet S. Bhangu, Paolo Bonato“... with Parkinson’s disease (PD) is a major challenge, both during clinical management and when conducting clinical...”
Publicado 2020
Enlace del recurso
article -
2por Kasandra Burgos, Ivana Malenica, Raghu Metpally, Amanda Courtright, Benjamin Rakela, Thomas Beach, Holly Shill, Charles Adler, Marwan Sabbagh, Stephen Villa, Waibhav Tembe, David Craig, Kendall Van Keuren-Jensen“... biofluids with neurodegenerative disease status of patients with Alzheimer's and Parkinson's diseases, we...”
Publicado 2014
Enlace del recurso
article -
3por Denis M. Nyaga, Mark H. Vickers, Craig Jefferies, Tayaza Fadason, Justin M. O’Sullivan“...-activated protein kinase activity, pertussis toxin signaling, and the Parkinson’s disease pathway. We...”
Publicado 2021
Enlace del recurso
article -
4por Chunhua Dong, Marion Hoffmann, Xi Li, Meijing Wang, Craig R. Garen, Nils O. Petersen, Michael T. Woodside“... to neurotoxicity associated with Parkinson’s disease and other neurodegenerative disorders. However, small...”
Publicado 2018
Enlace del recurso
article